EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TSC1 and TSC2 mRNA Processing Alterations in Tuberous Sclerosis Complex Patients With Negative or Inconclusive Genetic Testing Results

Arthur Bandeira de Mello Garcia, Taís da Silveira Fischer, Maria Clara de Freitas Pinho, Lucas Fernandes Jataí, Patrícia Santos da Silva, Tiago Finger Andreis, Larissa Brussa Reis, Cristina Brinckmann Oliveira Netto, Luiza Böhrer, Miguel Angelo Martins Moreira, Patricia Ashton-Prolla, Clévia Rosset

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/6691891 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, online erschienen am 20.11.2026. Verfasst von Arthur Bandeira de Mello Garcia und 11 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by the presence of pathogenic germline variants in TSC1 or TSC2 genes. However, most TSC1 and TSC2 genetic testing strategies arelimited and about 20% of patients have inconclusive or negative results. In this study, we standardized a technique based on RT‐PCR followed by Sanger sequencing, as a screening strategy aimed at complementing routine germline genetic testing. Whole transcriptome sequencing was performed for further investigation. Patients with clinical suspicion of TSC and TSC1 and TSC2 inconclusive ( n = 3) or negative ( n = 1) genetic testing results were recruited. RT‐PCR identified a nine base‐pair intronic inclusion in the TSC1 of an individual with a previously identified variant of uncertain significance (VUS), c.664‐10A>G. Additionally, whole transcriptome sequencing revealed two aberrant TSC2 transcripts in a patient harboring the VUS c.976‐3C>G. No aberrant mRNA alterations were detected in the remaining two patients. The present study was successful in identifying errors in mRNA processing in two TSC patients with previously inconclusive DNA genetic testing results, and our findings allowed reclassification of two VUS as pathogenic. Investigating the causality of intronic VUS is an effective strategy to complement coding region genetic testing in inconclusive and negative cases.

Förderung

  • Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Garcia, A. B. D. M., Fischer, T. D. S., Pinho, M. C. D. F., Jataí, L. F., Silva, P. S. D., Andreis, T. F., Reis, L. B., Netto, C. B. O., Böhrer, L., Moreira, M. A. M., Ashton-Prolla, P., & Rosset, C. (2026). TSC1 and TSC2 mRNA Processing Alterations in Tuberous Sclerosis Complex Patients With Negative or Inconclusive Genetic Testing Results. Human Mutation, 2026(1). https://doi.org/10.1155/humu/6691891

Vancouver

Garcia ABDM, Fischer TDS, Pinho MCDF, Jataí LF, Silva PSD, Andreis TF, et al. TSC1 and TSC2 mRNA Processing Alterations in Tuberous Sclerosis Complex Patients With Negative or Inconclusive Genetic Testing Results. Human Mutation. 2026;2026(1). doi:10.1155/humu/6691891

BibTeX
@article{Garcia2026,
  author = {Garcia, Arthur Bandeira de Mello and Fischer, Taís da Silveira and Pinho, Maria Clara de Freitas and Jataí, Lucas Fernandes and Silva, Patrícia Santos da and Andreis, Tiago Finger and Reis, Larissa Brussa and Netto, Cristina Brinckmann Oliveira and Böhrer, Luiza and Moreira, Miguel Angelo Martins and Ashton-Prolla, Patricia and Rosset, Clévia},
  title = {TSC1 and TSC2 mRNA Processing Alterations in Tuberous Sclerosis Complex Patients With Negative or Inconclusive Genetic Testing Results},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/6691891}
}
Kostenlos starten →